(Q45752122)

15 December 2017

title

Epstein-Barr virus gene expression in post-transplant lymphoproliferative disorders (English)

1 reference

15 December 2017

0 references

1

1 reference

15 December 2017

Gerald Niedobitek

series ordinal

2

1 reference

15 December 2017

author name string

Young LS

series ordinal

3

1 reference

15 December 2017

publication date

1 January 1998

1 reference

15 December 2017

Seminars in Immunopathology

published in

1 reference

15 December 2017

volume

20

1 reference

15 December 2017

issue

3-4

1 reference

15 December 2017

page(s)

389-403

1 reference

15 December 2017

Posttransplantation lymphoproliferative disorders frequently contain type A and not type B Epstein-Barr virus.

cites work

1 reference

12 December 2020

Analysis of Epstein-Barr virus gene polymorphisms in normal donors and in virus-associated tumors from different geographic locations

1 reference

12 December 2020

Epidemiology of infection with Epstein-Barr virus types 1 and 2: lessons from the study of a T-cell-immunocompromised hemophilic cohort

1 reference

12 December 2020

Distinction between Epstein-Barr virus type A (EBNA 2A) and type B (EBNA 2B) isolates extends to the EBNA 3 family of nuclear proteins.

1 reference

12 December 2020

Cloning and characterization of the latent membrane protein (LMP) of a specific Epstein-Barr virus variant derived from the nasopharyngeal carcinoma in the Taiwanese population

1 reference

12 December 2020

Precipitation of the Epstein-Barr virus protein EBNA 2 by an EBNA 3c-specific monoclonal antibody

1 reference

12 December 2020

Epstein-Barr virus (EBV) infection in infectious mononucleosis: virus latency, replication and phenotype of EBV-infected cells

1 reference

12 December 2020

Hodgkin's disease after transplantation

1 reference

12 December 2020

Sequence variation in the Epstein-Barr virus latent membrane protein 1.

1 reference

12 December 2020

Epstein-Barr virus latent and replicative gene expression in post-transplant lymphoproliferative disorders and AIDS-related non-Hodgkin's lymphomas. French Study Group of Pathology for HIV-associated Tumors

1 reference

12 December 2020

Patterns of Epstein-Barr virus latent and replicative gene expression in Epstein-Barr virus B cell lymphoproliferative disorders after organ transplantation.

1 reference

12 December 2020

Epstein-Barr virus (EBV)-associated lymphoproliferative disease in the SCID mouse model: implications for the pathogenesis of EBV-positive lymphomas in man

1 reference

12 December 2020

Restricted expression of EBV latent genes and T-lymphocyte-detected membrane antigen in Burkitt's lymphoma cells

1 reference

12 December 2020

Detection of heterogeneous Epstein-Barr virus gene expression patterns within individual post-transplantation lymphoproliferative disorders

1 reference

12 December 2020

Epstein-Barr virus-associated anaplastic large cell lymphoma in renal transplant patients

1 reference

12 December 2020

Three pathways of Epstein-Barr virus gene activation from EBNA1-positive latency in B lymphocytes

1 reference

12 December 2020

Epstein-Barr virus latent membrane protein-1 oncogene deletion in post-transplantation lymphoproliferative disorders

1 reference

12 December 2020

Identification of Epstein-Barr virus lytic activity in post-transplantation lymphoproliferative disease

1 reference

12 December 2020

A putative transforming gene of Jijoye virus differs from that of Epstein-Barr virus prototypes

1 reference

12 December 2020

Epstein-Barr virus types 1 and 2 differ in their EBNA-3A, EBNA-3B, and EBNA-3C genes

1 reference

12 December 2020

Monoclonal and polyclonal antibodies against Epstein-Barr virus nuclear antigen 5 (EBNA-5) detect multiple protein species in Burkitt's lymphoma and lymphoblastoid cell lines

1 reference

12 December 2020

Effect of a 10-amino acid deletion on the oncogenic activity of latent membrane protein 1 of Epstein-Barr virus.

1 reference

12 December 2020

HLA A2.1-restricted cytotoxic T cells recognizing a range of Epstein-Barr virus isolates through a defined epitope in latent membrane protein LMP2.

1 reference

12 December 2020

Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression

1 reference

12 December 2020

Heterogeneous expression of Epstein-Barr virus latent proteins in endemic Burkitt's lymphoma.

1 reference

12 December 2020

Mutations in the Epstein-Barr virus latent membrane protein-1 (BNLF-1) gene in spontaneous lymphoblastoid cell lines: effect on in vitro transformation associated parameters and tumorigenicity in SCID and nude mice

1 reference

12 December 2020

New type B isolates of Epstein-Barr virus from Burkitt's lymphoma and from normal individuals in endemic areas

1 reference

12 December 2020

Epstein-Barr virus-induced B-cell lymphoma after renal transplantation: acyclovir therapy and transition from polyclonal to monoclonal B-cell proliferation

1 reference

12 December 2020

Epstein-Barr virus nuclear antigen 2 activates transcription of the terminal protein gene

1 reference

12 December 2020

Redefining the Epstein-Barr virus-encoded nuclear antigen EBNA-1 gene promoter and transcription initiation site in group I Burkitt lymphoma cell lines

1 reference

12 December 2020

Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development

1 reference

12 December 2020

Expression of epstein-barr virus-encoded growth-transformation-associated proteins in lymphoproliferations of bone-marrow transplant recipients

1 reference

12 December 2020

Influence of the Epstein-Barr virus nuclear antigen EBNA 2 on the growth phenotype of virus-transformed B cells

1 reference

12 December 2020

Characterization of posttransplant lymphomas that express T-cell-associated markers: immunophenotypes, molecular genetics, cytogenetics, and heterotransplantation in severe combined immunodeficient mice

1 reference

12 December 2020

Molecular profile of Epstein-Barr virus in human immunodeficiency virus type 1-related lymphadenopathies and lymphomas

1 reference

12 December 2020

Epstein-Barr virus--determined clonality in posttransplant lymphoproliferative disease.

1 reference

12 December 2020

Epstein-Barr virus (EBV) in endemic Burkitt's lymphoma: molecular analysis of primary tumor tissue.

1 reference

12 December 2020

Clonability and tumorigenicity of human epithelial cells expressing the EBV encoded membrane protein LMP1.

1 reference

12 December 2020

The 30-base-pair deletion in Chinese variants of the Epstein-Barr virus LMP1 gene is not the major effector of functional differences between variant LMP1 genes in human lymphocytes.

1 reference

12 December 2020

Identification of cytotoxic T cell epitopes within Epstein-Barr virus (EBV) oncogene latent membrane protein 1 (LMP1): evidence for HLA A2 supertype-restricted immune recognition of EBV-infected cells by LMP1-specific cytotoxic T lymphocytes

1 reference

12 December 2020

Differentiation-associated expression of the Epstein-Barr virus BZLF1 transactivator protein in oral hairy leukoplakia

1 reference

12 December 2020

Recurrent Epstein-Barr virus-associated lesions in organ transplant recipients

1 reference

12 December 2020

The expression of Epstein-Barr virus latent proteins is related to the pathological features of post-transplant lymphoproliferative disorders

1 reference

12 December 2020

Human CD8+ T cell responses to EBV EBNA1: HLA class I presentation of the (Gly-Ala)-containing protein requires exogenous processing

1 reference

12 December 2020

Rat monoclonal antibodies differentiating between the Epstein-Barr virus nuclear antigens 2A (EBNA2A) and 2B (EBNA2B).

1 reference

12 December 2020

Epstein-Barr virus-associated T-cell lymphoma in a renal transplant patient

1 reference

12 December 2020

Down-regulation of class I HLA antigens and of the Epstein-Barr virus-encoded latent membrane protein in Burkitt lymphoma lines

1 reference

12 December 2020

Transmission of donor Epstein-Barr virus (EBV) in transplanted organs causes lymphoproliferative disease in EBV-seronegative recipients

1 reference

12 December 2020

Post-transplant lymphoproliferative disorders with genetic abnormalities commonly found in malignant tumours

1 reference

12 December 2020

U2 region of Epstein-Barr virus DNA may encode Epstein-Barr nuclear antigen 2

1 reference

12 December 2020

Molecular epidemiology of Epstein-Barr virus infection

1 reference

12 December 2020

Recognition of the Epstein-Barr virus-encoded nuclear antigens EBNA-4 and EBNA-6 by HLA-A11-restricted cytotoxic T lymphocytes: implications for down-regulation of HLA-A11 in Burkitt lymphoma

1 reference

12 December 2020

Epstein-Barr virus strain variation in nasopharyngeal carcinoma from the endemic and non-endemic regions of China

1 reference

12 December 2020

Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23

1 reference

12 December 2020

Different Epstein-Barr virus-B cell interactions in phenotypically distinct clones of a Burkitt's lymphoma cell line

1 reference

12 December 2020

Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1.

1 reference

12 December 2020

Epstein-Barr virus latent membrane protein-1 oncogene deletions: correlations with malignancy in Epstein-Barr virus--associated lymphoproliferative disorders and malignant lymphomas.

1 reference

12 December 2020

Epstein-Barr virus-latent gene expression and tumor cell phenotype in acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma. Correlation of lymphoma phenotype with three distinct patterns of viral latency

1 reference

12 December 2020

Biology and adoptive cell therapy of Epstein-Barr virus-associated lymphoproliferative disorders in recipients of marrow allografts.

1 reference

12 December 2020

Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies

1 reference

12 December 2020

Geographical prevalence of two types of Epstein-Barr virus

1 reference

12 December 2020

The Epstein-Barr virus carrier state: dominance of a single growth-transforming isolate in the blood and in the oropharynx of healthy virus carriers

1 reference

12 December 2020

Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of posttransplantation lymphoproliferative disorders

1 reference

12 December 2020

Characterization of the Epstein-Barr virus Fp promoter

1 reference

12 December 2020

Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease

1 reference

12 December 2020

Immunohistology of Epstein-Barr virus-associated antigens in B cell disorders from immunocompromised individuals

1 reference

12 December 2020

Epstein-Barr virus infection and malignant lymphomas in liver transplant recipients

1 reference

12 December 2020

The Epstein-Barr virus latent membrane protein-1 (LMP1) mediates activation of NF-kappa B and cell surface phenotype via two effector regions in its carboxy-terminal cytoplasmic domain.

1 reference

12 December 2020

Epstein-Barr virus nuclear antigen 2 transactivates latent membrane protein LMP1.

1 reference

12 December 2020

Control of virus-induced lymphoproliferation: Epstein-Barr virus-induced lymphoproliferation and host immunity

1 reference

12 December 2020

Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt's lymphoma cells

1 reference

12 December 2020

Identifiers

DOI

10.1007/S002810050043

1 reference

15 December 2017

PubMed ID

9870253

1 reference

15 December 2017